NCT02872792

Brief Summary

Cycloergometer is a validated method for different care. This kind of device allow passive and active care for patient. The interest of cycloergometer for patient hospitalized in Intensive Care Unit for Sepsis has never been demonstrated. The main objective of this study is to determine the impact of early mobilization by cyclo-ergometer in association with standard physiotherapy, on the ICU length in patients with septic shock The secondary objectives of this study are to assess the impact of early mobilization by cyclo-ergometer in association with standard physiotherapy on:

  1. 1.the duration between hemodynamic stability\* and the removal of sedation
  2. 2.the duration between the removal of sedation and ICU discharge
  3. 3.the mechanical ventilation duration (invasive and noninvasive)

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
122

participants targeted

Target at P50-P75 for not_applicable sepsis

Timeline
Completed

Started Dec 2016

Longer than P75 for not_applicable sepsis

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 19, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

December 14, 2016

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 21, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 21, 2020

Completed
Last Updated

March 29, 2022

Status Verified

March 1, 2022

Enrollment Period

3.4 years

First QC Date

August 16, 2016

Last Update Submit

March 14, 2022

Conditions

Keywords

cycloergometer

Outcome Measures

Primary Outcomes (1)

  • Number of days between hemodynamic stability and ICU discharge

    Number of days between hemodynamic stability (after beginning of hospitalization for sepsis) and ICU discharge

    approximately 1 month

Secondary Outcomes (2)

  • Number of days between hemodynamic stability and the removal of sedation

    From 3 to 10 days

  • Number of days under mechanical ventilation (invasive and noninvasive) during hospitalization in ICU

    From 3 to 10 days

Study Arms (2)

Early mobilisation with cyclo ergometer

EXPERIMENTAL

Early mobilisation with cyclo ergometer in addition of Standard physiotherapy during sepsis for patient with sepsis in ICU

Device: Early mobilisation with cyclo ergometerOther: Standard physiotherapy

Standard physiotherapy

ACTIVE COMPARATOR

Standard physiotherapy during sepsis for patient with sepsis in ICU

Other: Standard physiotherapy

Interventions

Early mobilisation with cyclo ergometer is done daily during hospitalization for sepsis in an Intensive Care Unit

Early mobilisation with cyclo ergometer

Standard physiotherapy included passive and active manual mobilization, sitting on bed, sitting in chair, walking

Early mobilisation with cyclo ergometerStandard physiotherapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient hospitalized in ICU
  • Patient hemodynamically stable, before the 72th hour following the diagnosis of septic shock
  • Mechanical ventilation by tracheal intubation
  • Patient sedated with a RASS score inferior or equal to -2
  • Age ≥ 18 years
  • BMI ≤ 40 kg / m²
  • Informed patient having signed the consent
  • Effective contraception in women of childbearing age (pregnancy test by B-HCG will be done; for menopausal women, a diagnosis of confirmation must be obtained).

You may not qualify if:

  • BMI\> 40kg / m²
  • Patient reduced by one or two lower limbs
  • Rheumatological pathology, trauma or surgery of the lower limbs, pelvis or spine resulting of any limitations of the range of motions or strict immobilization
  • Brain-injured patient and / or medulla injured
  • Hemodialysis continues with a femoral catheter without possibility of changing the catheter location
  • Moribund patient, Stop or Limitation of Active Therapeutics' decision
  • Contraindications to standard physical therapy or the cyclo-ergometer
  • Untreated orthopedics: deep vein thrombosis of the member concerned
  • Dermatological: severe lesions or complex dressings in the sector concerned
  • Patient with ExtraCorporeal Membrane Oxygenation (ECMO)
  • Pregnant or breastfeeding women
  • Patient participating in another trial with the same main objective

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rouen University Hospital

Rouen, France

Location

MeSH Terms

Conditions

Sepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Gaétan BEDUNEAU, MD

    University Hospital, Rouen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2016

First Posted

August 19, 2016

Study Start

December 14, 2016

Primary Completion

April 21, 2020

Study Completion

April 21, 2020

Last Updated

March 29, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations